Capillary pressure barriers
US-2015238952-A1 · Aug 27, 2015 · US
US11504645B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-11504645-B2 |
| Application number | US-201414898813-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jun 19, 2014 |
| Priority date | Jun 19, 2013 |
| Publication date | Nov 22, 2022 |
| Grant date | Nov 22, 2022 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present invention relates to a process for the electro extraction of molecules from a moving fluid donor phase into an acceptor phase, comprising the steps of: providing an electrically conductive donor phase moving at a first flow velocity and in electrically conductive contact with a first electrode, providing an electrically conductive acceptor phase in direct contact and immiscible with the donor phase, in electrically conductive contact with a second electrode; and providing a supporting or confining phase guide pattern to keep a defined interface between donor phase and acceptor phase, and (d) applying an electrical field between the first and the second electrode.
Opening claim text (preview).
The invention claimed is: 1. A process for an electroextraction of organic compounds from a moving fluid donor phase into an acceptor phase, the process comprising: providing an electrically conductive donor phase moving at a first flow velocity and in electrically conductive contact with a first electrode; providing an electrically conductive acceptor phase in direct contact and immiscible with the donor phase, in electrically conductive contact with a second electrode; providing a supporting or confining phase guide pattern having a sharp edge to keep a defined interface between the donor phase and the acceptor phase, wherein the sharp edge is shaped such that advancement of a fluid over the sharp edge requires a change of a principal radii of a fluid-fluid meniscus, leading to a higher pressure drop over the fluid-fluid meniscus thus representing a pressure barrier; and applying an electrical field between the first electrode and the second electrode, wherein the electrical field has a current between 0.01 μA and 100 μA for an interface length of 8 mm; wherein one of the donor phase and the acceptor phase is an organic phase and an other of the donor phase and the acceptor phase is an aqueous phase; and wherein the acceptor phase is moving at a second flow velocity which is lower than the first flow velocity. 2. The process according to claim 1 , wherein the acceptor phase is moving co-directionally with the donor phase. 3. The process according to claim 1 , wherein the donor phase and/or the acceptor phase remain immiscible during the process. 4. The process according to claim 1 , wherein the electrical field is applied sufficiently high and in a sufficiently long period of time to allow at least part of the organic compounds to migrate from the donor phase to the acceptor phase, or to the defined interface between the donor phase and the acceptor phase. 5. The process according to claim 1 , wherein a further acceptor phase is present at an opposite side of the acceptor phase and in direct contact with the donor phase, and wherein the first electrode is arranged in the further acceptor phase, and wherein the electrically conductive contact with the donor phase occurs through the further acceptor phase. 6. The process according to claim 1 , further comprising: removing the acceptor phase comprising migrated analytes; and subjecting the removed acceptor phase to a further separation and/or analysis process. 7. The process according to claim 6 , wherein the further separation and/or analytical process comprises one or more of liquid chromatography (LC), reversed phase (RP) LC, normal phase (NP) LC, thin layer chromatography (TLC), capillary electrophoresis (CE), nuclear magnetic resonance (NMR), mass spectrometry (MS) gas chromatography/mass spectrometry (GC/MS), GC-MS/MS, nanoelectrospray-Direct-Infusion-MS, ultraviolet/visible light (UV/VIS), nano LC, high-performance liquid chromatography (HPLC), ultra-high performance LC (UPLC); RP-(UV/VIS)-EV-NP-MS, RP-(UV/VIS)-EV-NMR, NP-(UV/VIS)-EV-CE-MS/RP-(UV/VIS)-EV-CE-MS, RP(UV/VIS)-EV-TLC/NP-(UV/VIS)-EV-TLC, EV-nano LC, and CE-EV. 8. The process according to claim 1 , wherein the donor phase is a result of a previous separation and/or analysis process. 9. The process according to claim 1 , wherein the organic compounds are selected from pharmaceuticals, drugs, coloring agents, food additives, metabolites, nucleotides (such as DNA or RNA), proteins, peptides, amino acids, carbohydrates, lipids, polysaccharide fatty acids or phospholipids.
membraneless transfer of a component between two parallel laminar flows of fluid · CPC title
Electrodes · CPC title
Focussing flows, e.g. to laminate flows · CPC title
in combination with an electric or magnetic field or with vibrations · CPC title
by extraction in microfluidic devices · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.